By Kurt M. Campbell and Rush Doshi
KURT M. CAMPBELL is Chair and CEO of the Asia Group and was U.S. Assistant Secretary of State for East Asian and Pacific Affairs from 2009 to 2013.
On this episode of Anti-Aging Hacks, we discuss all about reversing aging in humans! My guest in this podcast is Dr. Greg Fahy, and he is the first scientist to reverse aging in humans. Here is what we discuss in this interview: 1. Why the Thymus is really important for Immune Function 2. How creating a combination.
The Tentacle Bot
Posted in robotics/AI
I would love to see this on a long handle to grab the stuff I can’t get to. http://robohub.org/ lead me here after seeing Sabine Hauert do a talk on micro-swarms.
Scientists took conspiracy theories seriously and analyzed the coronavirus to reveal its natural origins.
By Bill D’Zio Originally published on www.westeastspace.com
Parachutes are plaguing space programs. SpaceX doesn’t like Parachutes. They are difficult to design, hard to package, and easy to damage. The larger the mass of the spacecraft, the more effort to slow down. Larger, more efficient, complex parachute systems are needed. Several failures have hit the industry over the last few years, including SpaceX Crew Dragon, ESA ExoMars, Boeing CST-100, and the NASA Orion to name a few.
How do parachutes work and why are they hard?
Derek Haoyang Li, the founder of Squirrel AI Learning, is a serial entrepreneur who co-founded two publicly listed companies, and one of the companies has a market cap of $200 million. Squirrel AI Learning is the leading AI + education innovator and unicorn at the forefront of the K12 AI revolution. Within three years of its product release, Squirrel AI Learning has established more than 2,600+ learning centers in China and hosted the first series of human-vs-AI competitions in the Asia-Pacific region that proved the AI’s success. Squirrel AI Learning is recognized by Deloitte as one of the top 10 global AI enterprises with high growth. Squirrel AI Learning was also included in MIT Technology Review’s TR50 Smartest Companies in China list. Stanford Graduate School of Business has also published a case study on Squirrel AI Learning.
CHECK OUT SEASON 1 PLAYLIST: https://www.youtube.com/watch?v=ic9AV4mMbOQ&list=PL_GIV9cvJ8…itbMC34bPF
KEEP THE SHOW ON-AIR! : WWW.PATREON.COM/DEBTNATION
• PLEASE CHECK OUR SPONSOR: WWW.IAMTRANSHUMAN.ORG/
• LINK TO BOOK: https://www.amazon.com/Transhumanism-Handbook-Newton-Lee/dp/…atfound-20
Officials are working out final details in plans to begin clinical trials next week for a malaria drug combination that appears to hold some promise for confronting the coronavirus pandemic.
New York state Health Department officials are making arrangements to determine what patients at which hospitals will be allowed to participate in trials with hydroxychloroquine, Zithromax and chloroquine, a senior official at the department with knowledge of the plan told ABC News. The bulk of the patients are expected to be in the New York City metro area because the region has the biggest cluster of cases.
New York Gov. Andrew Cuomo announced earlier this week that he was eager to get the trials started. By Tuesday, the drugs were in New York and officials were working to identify who could participate.
The medications, originally developed to fight malaria, have raised hope among many that they could aid in treating coronavirus. The core of the medical therapy is chloroquine, closely related to hydroxychloroquine, which has been used to treat malaria since 1944. It can be given before exposure to malaria to prevent infection, and it can also be given as treatment afterward. It’s also currently used to treat autoimmune diseases like lupus. Doctors are adding the antibiotic Zithromax to the cocktail.